Patent details
EP3067054 Title: NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT
Basic Information
- Publication number:
- EP3067054
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP161562780
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT
- French Title of Invention:
- COMPOSITIONS ET PROCÉDÉS NOUVEAUX POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- NEUE ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIE BEKÄMPFUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 10/09/2008
- Grant date:
- 30/12/2020
- EP Publication Date:
- 14/09/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/12/2020
- EP B1 Publication Date:
- 30/12/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/09/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/12/2020
- Name:
- Boston Biomedical, Inc.
- Address:
- 640 Memorial Drive, Cambridge, MA 02139, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 16/02/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- LI, Chiang, Jia
- Address:
- United States (US)
2
- Name:
- LI, Youzhi
- Address:
- United States (US)
3
- Name:
- MIKULE, Keith
- Address:
- United States (US)
Priority
1
- Priority Number:
- 971144 P
- Priority Date:
- 10/09/2007
- Priority Country:
- United States (US)
2
- Priority Number:
- 13372
- Priority Date:
- 13/12/2007
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/505; A61K 31/55; A61K 38/17; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 202053
- Publication date:
- 30/12/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 281 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 09/09/2025
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- Beijing Guozhuan Intellectual Property Ltd
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/02/2021 | Outgoing Correspondence | 1 |
| 16/02/2021 | Power Of Attorney | 1 |